Rycaj Kiera, Li Hangwen, Zhou Jianjun, Chen Xin, Tang Dean G
Department of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Department of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA; Cancer Stem Cell Institute, Research Center for Translational Medicine, East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Semin Cancer Biol. 2017 Jun;44:83-97. doi: 10.1016/j.semcancer.2017.03.009. Epub 2017 Apr 11.
Metastasis causes more than 90% of cancer-related deaths and most prostate cancer (PCa) patients also die from metastasis. The 'metastatic cascade' is a complex biological process that encompasses tumor cell dissociation (from the primary tumor), local invasion, intravasation, transport in circulation, extravasation, colonization, and overt growth in end organs. It has become clear that successful metastasis not only involves many tumor cell-intrinsic properties but also depends on productive interactions between cancer cells and the tumor microenvironment. In this Review, we begin with a general summary on cancer metastasis and a specific discussion on PCa metastasis. We then discuss recent advances in our knowledge of the cellular determinants of PCa metastasis and the importance of tumor microenvironment, especially an immunosuppressive tumor microenvironment, in shaping metastatic propensities. We conclude with a presentation of current and future therapeutic options for patients with PCa metastasis, emphasizing the development of novel, mechanism-based combinatorial strategies for treating metastatic and castration-resistant PCa.
转移导致超过90%的癌症相关死亡,大多数前列腺癌(PCa)患者也死于转移。“转移级联反应”是一个复杂的生物学过程,包括肿瘤细胞从原发肿瘤解离、局部侵袭、血管内渗入、循环运输、血管外渗、定植以及在终末器官中的明显生长。已经明确的是,成功的转移不仅涉及许多肿瘤细胞内在特性,还取决于癌细胞与肿瘤微环境之间的有效相互作用。在本综述中,我们首先对癌症转移进行总体概述,并对PCa转移进行具体讨论。然后,我们讨论了我们对PCa转移的细胞决定因素的最新认识进展,以及肿瘤微环境,特别是免疫抑制性肿瘤微环境在塑造转移倾向方面的重要性。我们最后介绍了PCa转移患者当前和未来的治疗选择,强调开发用于治疗转移性和去势抵抗性PCa的基于机制的新型联合策略。